Patients on chronic opioid prescriptions were 3x more likely to die of an overdose in the years that followed coming off opioids UNIVERSITY OF WASHINGTON HEALTH SCIENCES/UW MEDICINE With a huge push to reduce opioid prescribing, little is known about the real-world benefits or risks to patients. A recent study published in the Journal of General Internal Medicine found an alarming outcome: Patients coming off opioids for pain were three times...
Tag: <span>Opioid</span>
Post
TEENS WHO MISUSE OPIOIDS HAVE THESE SOURCES
Roughly 11% of high school seniors reported prescription drug misuse during the past year, and of those, 44% used multiple supply sources, according to new research. More than 70% of adolescents who obtained prescription drugs from multiple sources had a substance use disorder—involving prescription medications, other drugs, and alcohol—within the previous year. The national average...
Post
Federal Judge Orders Release Of Dataset Showing Drug Industry’s Role In Opioid Crisis
BRIAN MANN For the first time, a federal court in Ohio is releasing a trove of data that offers far more detail about the size and scope of the nation’s opioid epidemic – and about the role played by drug companies and pharmacies like CVS, Walgreens and Johnson & Johnson that profited from the rapid...
Post
OPIOID ADDICTION DOESN’T ALWAYS START WITH THE DOCTOR
Nonmedical opioid users are more likely to start abusing the drug after getting them from friends or family members—not doctors—according to a new study. Many people may think heroin abuse begins after doctors prescribe opioids and patients become addicted to them. When the government cracked down on prescription opioids and drug manufacturers began making pills more difficult to get...
Post
CBD: The next weapon in the war against opioid addiction?
by Jenny Wilkerson And Lance Mcmahon, The Conversation CBD, or cannabidiol, is everywhere, with word on the street saying that it can cure everything from a bad mood to cancer. However, most of these claims are not based on scientific evidence. Animal studies suggest that CBD might be beneficial for some health indications, such as pain, inflammation, arthritis and anxiety. However, until recently,...
Post
Generic Anti-Overdose Nasal Spray Gets FDA Approval
To combat the problem of increasing death rate in the United States due to opioid overdose, the FDA has approved a generic variant of naloxone. Naloxone is a drug used to rapidly reverse the effects of an opioid overdose and prevent death. The medication will come in the form of a nasal spray and it will be easily administered by anyone to help a patient who...
Post
Medications to treat opioid addiction are effective, though not widely used
by Neil Schoenherr, Washington University School of Medicine in St. Louis With more than 2 million Americans suffering from an opioid use disorder and the escalating rate of deaths from opioidoverdoses reaching about 130 per day, efforts to date have had little impact in curbing this crisis across the country. As a result, a committee of the National Academies...
Post
Early physical therapy can reduce risk, amount of long-term opioid use, study finds
Patients who underwent physical therapy soon after being diagnosed with pain in the shoulder, neck, low back or knee were approximately 7 to 16 percent less likely to use opioids in the subsequent months, according to a new study by researchers at the Stanford University School of Medicine and the Duke University School of Medicine....
Post
New non-addictive compound could treat pain and opioid abuse
With an addiction to prescription painkillers a major part of the current opioid crisis in the US, the search for an effective but non-addictive pain medication is on in earnest. And researchers at Wake Forest School of Medicine appear to have found a likely candidate in the form of a chemical compound called AT-121. With promising results...
Post
Providing clinicians feedback on their Opioid prescribing data alters future prescribing
DES PLAINES, IL — Asking emergency department (ED) providers to self-identify their opioid prescribing practices and then providing them with timely, clinically relevant, individualized, and actionable feedback on their actual opioid prescribing data, significantly decreases future opioid prescribing among providers who underestimate their baseline prescribing. That is the finding of a study to be published...